Skip to main content
Top
Published in: Journal of General Internal Medicine 5/2016

01-05-2016 | Clinical Images

Pyoderma Gangrenosum After Enzymatic Debridement

Authors: Mark Duncan, M.D., Scott Worswick, M.D.

Published in: Journal of General Internal Medicine | Issue 5/2016

Login to get access

Excerpt

An 80-year-old man with a history of IgA monoclonal gammopathy presented with a painful ulcerative lesion on his right knee (Fig. 1) that had developed in response to a lanced pustule. Failure of empiric antibiotics led to a punch biopsy, which showed nonspecific acute and chronic inflammation. A diagnosis of pyoderma gangrenosum was made based on negative tissue cultures, characteristic pain, and a classic clinical appearance. Oral cyclosporine resulted in improvement of the lesion. After discharge, he was lost to follow-up, discontinued the use of cyclosporine, and consulted an outside wound care provider, who initiated a regimen containing topical collagenase for enzymatic debridement. The patient was readmitted with worsening of the lesion (Fig. 2) and hemodynamically significant bleeding. He required blood transfusions but responded well to oral prednisone and avoidance of further mechanical and chemical trauma.
Literature
1.
go back to reference Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. 2012;13(3):191–211.CrossRefPubMed Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. 2012;13(3):191–211.CrossRefPubMed
2.
go back to reference Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011;165(6):1244–50.CrossRefPubMed Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011;165(6):1244–50.CrossRefPubMed
3.
go back to reference Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum: a review of 86 patients. Q J Med. 1985;55(217):173–86.PubMed Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum: a review of 86 patients. Q J Med. 1985;55(217):173–86.PubMed
4.
go back to reference Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum and monoclonal gammopathy. Arch Dermatol. 1983;119(6):468–72.CrossRefPubMed Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum and monoclonal gammopathy. Arch Dermatol. 1983;119(6):468–72.CrossRefPubMed
Metadata
Title
Pyoderma Gangrenosum After Enzymatic Debridement
Authors
Mark Duncan, M.D.
Scott Worswick, M.D.
Publication date
01-05-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 5/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3532-y

Other articles of this Issue 5/2016

Journal of General Internal Medicine 5/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine